Pharma Journalist -

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Philadelphia 2020 into a completely virtual event. To safeguard the…
Read More...

CROMSOURCE, an international contract research organization (CRO) with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the New Drug Application (NDA) of…
Read More...

SMi Reports: Associates of Cape Cod to host an online webinar taking place on Wednesday 29th April 2020. SMi Group is delighted to announce a free webinar led by Associates of Cape…
Read More...

SMi Reports: Novartis presentation details released for the Injectable Drug Delivery conference, this September The highly anticipated 3rd annual Injectable Drug Delivery conference,…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses,…
Read More...

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a monotherapy…
Read More...

Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring and Takeda Pharmaceutical Company Limited to develop a potential plasma-derived therapy for treating…
Read More...

Servier, an independent international pharmaceutical company, announced that it has entered into a definitive agreement with the owners of Symphogen A/S, a leader in therapeutic…
Read More...

XBiotech Inc. and BioBridge Global announced their collaboration to participate in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin…
Read More...